An XNA-CRISPR Platform for PAM-Free Detection of the katG Ser315Thr Mutation Associated with Isoniazid Resistance in Tuberculosis
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c02379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Xinyi Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument, School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen …. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Isoniazid, Bacterial Proteins, Drug Resistance, Bacterial. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Science and Technology Foundation of Shenzhen City, Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument, National Natural Science Foundation of China.
Abstract (Originalsprache)
Drug-resistance Tuberculosis (TB) is a major threat to global public health. Simple and precise detection of the mutations associated with drug resistance is still a significant challenge. CRISPR-based nucleic acid detection has emerged as a transformative technology in molecular diagnostics due to its high specificity and programmability. However, the CRISPR-Cas12a system requires a protospacer adjacent motif (PAM) in the target double-stranded DNA (dsDNA) for efficient recognition and activation, which limits its application for detecting single-nucleotide variants (SNVs). To overcome this limitation, we leveraged high-affinity xenonucleic acids (XNAs) to engineer an XNA-CRISPR platform that combines a helicase and sequence-specific XNAs (such as peptide nucleic acid (PNA), locked nucleic acid (LNA), or 2′-modified RNA), to unwind the dsDNA, enabling them to invade and form stable hybrids, thereby displacing a single strand for PAM-independent Cas12a activation. This recognition mechanism, combining XNA hybridization and CRISPR verification, achieves single-base resolution. To bridge the sensitivity gap for clinical application, we integrated this platform with polydisperse droplet digital technology (PddXNA-CRISPR), which significantly enhanced the sensitivity. Clinical sputum samples were detected by using PddXNA-CRISPR for Mycobacterium tuberculosis (MTB) katG Ser315Thr mutation, which showed 90% concordance with sequencing results. This modular, amplification-free platform expands the CRISPR-based diagnostic toolkit and provides a versatile and sensitive approach for detecting critical SNVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument, School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen518107, China.
- School of Public Health (Shenzhen), Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Guangdong518107, China.
- Zhejiang Key Laboratory of Multiomics and Molecular Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, Zhejiang314006, China.
ORCID-Profile: Jianhua Zhou, Jiasi Wang
Förderung
- Science and Technology Foundation of Shenzhen City
- Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Medical Research Fund
- China Resources Research Institute of Science & Technology
Zitieren
APA
Liao, X., Chen, J., Wan, Y., Xu, W., Zhou, J., Liu, Y., Li, X., Yang, C., & Wang, J. (2026). An XNA-CRISPR Platform for PAM-Free Detection of the katG Ser315Thr Mutation Associated with Isoniazid Resistance in Tuberculosis. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c02379
Vancouver
Liao X, Chen J, Wan Y, Xu W, Zhou J, Liu Y, et al. An XNA-CRISPR Platform for PAM-Free Detection of the katG Ser315Thr Mutation Associated with Isoniazid Resistance in Tuberculosis. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c02379
BibTeX
@article{Liao2026,
author = {Liao, Xinyi and Chen, Junhong and Wan, Yunzhu and Xu, Wenfei and Zhou, Jianhua and Liu, Yanping and Li, Xuhui and Yang, Chongguang and Wang, Jiasi},
title = {An XNA-CRISPR Platform for PAM-Free Detection of the katG Ser315Thr Mutation Associated with Isoniazid Resistance in Tuberculosis},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c02379}
}
EUVIMED